Spanish oncology center under threat

Retention of ionizable compounds on HPLC. 5. pH scales and the retention of acids and bases with acetonitrile-water mobile phases

Analytical chemistry·2000

Direct evidence of a radical mechanism in the addition reaction of iododifluoroesters to olefins by spin trapping

The Journal of organic chemistry·2000

Cationic and neutral diphenyldiazomethanerhodium(I) complexes as catalytically active species in the C-C coupling reaction of olefins and diphenyldiazomethane

Chemistry (Weinheim an der Bergstrasse, Germany)·2000

Fourier Transform Spectra of the E(2)Pi(u)-X(2)Pi(g)((3/2)) System of CuCl(2).

Journal of molecular spectroscopy·2000

Introduction of heteroatom-based substituents into 1,4-dihydropyridines by means of a halogen-mediated, oxidative protocol: diamination, sulfonylation, sulfinylation, bis-sulfanylation, and halo-phosphonylation processes

Chemistry (Weinheim an der Bergstrasse, Germany)·2000

Oxidative diphosphonylation of 1,4-dihydropyridines and pyridinium salts

Organic letters·2000

Histological aging signatures for monitoring tissue-specific aging and disease.

Nature medicine·2026

How to build an AI-driven digital organism.

Nature medicine·2026

First-line PD-1/VEGF bispecific antibody plus chemotherapy in triple-negative breast cancer: a phase 2 trial.

Nature medicine·2026

Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer.

Nature medicine·2026

Decade-long persistence of CD19 CAR T cells in B cell lymphomas.

Nature medicine·2026

Obinutuzumab β for aquaporin-4-positive neuromyelitis optica spectrum disorder: a phase 3 randomized controlled trial.

Nature medicine·2026

Synergistic cell-cycle repression by HDAC/EZH2 co-targeting in H3K27-altered diffuse midline glioma.

Molecular therapy. Oncology·2026

In-depth characterization of stem cell potency and genotoxicity for clinical-scale ex vivo CRISPR-Cas9 gene editing.

Molecular therapy. Advances·2026

m6A-dependent regulation of DGUOK-AS1 by RBM15 and HNRNPH1 in lung adenocarcinoma.

iScience·2026

Metabolic reprogramming in pancreatic cancer: interplay of glucose, lipid, and amino acid metabolism in tumor progression.

Cytotechnology·2026

Baicalein targets the Nrf2/Keap1 interaction and related stress pathways to mitigate drug-induced toxicity and reverse resistance in breast cancer: A review.

International journal of biological macromolecules·2026

Exosomes as next-generation drug carriers: Transforming cancer therapy.

Journal of controlled release : official journal of the Controlled Release Society·2026

Related Experiment Videos

Spanish oncology center under threat

Related Concept Videos

Retention of ionizable compounds on HPLC. 5. pH scales and the retention of acids and bases with acetonitrile-water mobile phases

Direct evidence of a radical mechanism in the addition reaction of iododifluoroesters to olefins by spin trapping

Cationic and neutral diphenyldiazomethanerhodium(I) complexes as catalytically active species in the C-C coupling reaction of olefins and diphenyldiazomethane

Fourier Transform Spectra of the E(2)Pi(u)-X(2)Pi(g)((3/2)) System of CuCl(2).

Introduction of heteroatom-based substituents into 1,4-dihydropyridines by means of a halogen-mediated, oxidative protocol: diamination, sulfonylation, sulfinylation, bis-sulfanylation, and halo-phosphonylation processes

Oxidative diphosphonylation of 1,4-dihydropyridines and pyridinium salts

Histological aging signatures for monitoring tissue-specific aging and disease.

How to build an AI-driven digital organism.

First-line PD-1/VEGF bispecific antibody plus chemotherapy in triple-negative breast cancer: a phase 2 trial.

Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer.

Decade-long persistence of CD19 CAR T cells in B cell lymphomas.

Obinutuzumab β for aquaporin-4-positive neuromyelitis optica spectrum disorder: a phase 3 randomized controlled trial.

Synergistic cell-cycle repression by HDAC/EZH2 co-targeting in H3K27-altered diffuse midline glioma.

In-depth characterization of stem cell potency and genotoxicity for clinical-scale ex vivo CRISPR-Cas9 gene editing.

m6A-dependent regulation of DGUOK-AS1 by RBM15 and HNRNPH1 in lung adenocarcinoma.

Metabolic reprogramming in pancreatic cancer: interplay of glucose, lipid, and amino acid metabolism in tumor progression.

Baicalein targets the Nrf2/Keap1 interaction and related stress pathways to mitigate drug-induced toxicity and reverse resistance in breast cancer: A review.

Exosomes as next-generation drug carriers: Transforming cancer therapy.

Related Experiment Videos

Spanish oncology center under threat

Related Concept Videos

Related Articles